The Market Herald - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Australian milk powder wholesalers Jatenergy has signed an agreement with Chinese tech group – HIT Crown, granting access to the Chinese medicine market.

HIT Crown manages the online Medicine E-Business and specialises in cloud-based servers in the Chinese market. China Golden, services over one million pharmaceutical companies, hospitals and clinics in the Chinese market.

This Memorandum of Understanding grants JAT access to sell its milk formulas Neurio and Golden Koala through HIT Crown’s online network.

Jatenergy Managing Director Wilton Yao says the agreement provides a framework to service the Chinese middle-class household.

“We are very comfortable about the future sales of our in-house brands as more and more Chinese and overseas distributors express their wish to work together with Jatenergy to promote our products through strategic partnerships,” he said.

Please see the announcement attached

JAT by the numbers
More From The Market Herald

Cynata Therapeutics receives approval to launch phase two trial of CYP-001 in Turkey

Cell therapy company, Cynata Therapeutics (ASX:CYP) has received regulatory and ethics approval to commence a phase…

Little Green Pharma positions itself for growth in France’s emerging medicinal cannabis market

Little Green Pharma (ASX:LGP) is primed for substantial growth after a major amendment to the French…

PolyNovo posts $8m sales month and $9m revenue month for November

Disruptive medical device company PolyNovo (ASX:PNV) has announced record monthly sales of $8.8 million for November…
Imugene (ASX:IMU) - Managing Director & CEO, Leslie Chong

Imugene set to secure European patent for cancer vaccine; announces new phase II CRC cancer trial in 2024

Imugene (ASX:IMU) is on the verge of securing approval from the European Patent Office (EPO) for…